ABOUT MODAFINIL NORGE

Steer clear of concomitant usage of tucatinib with CYP3A substrates, where by small focus changes might bring about significant or lifetime-threatening toxicities. If unavoidable, reduce CYP3A substrate dose Based on merchandise labeling.Using this medication with any of the next medicines is usually not recommended, but could possibly be necessary